Drug Type Recombinant protein, Diagnostic radiopharmaceuticals |
Synonyms 99mTc-rhAnnexin V-128, 99mTechnetium-labelled rhAnnexin V-128, Tc-99m-recombinant human annexin V-128 + [2] |
Target |
Mechanism Phosphatidylserine inhibitors(Phosphatidylserine inhibitors), SPECT(Single-photon emission-computed tomography enhancers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Spondylarthritis | Phase 2 | US | 18 Sep 2017 | |
Endocarditis, Bacterial | Phase 2 | FR | 05 Feb 2016 | |
Thrombosis | Phase 2 | FR | 05 Feb 2016 | |
Ankylosing Spondylitis | Phase 2 | CH | 11 Dec 2014 | |
Rheumatoid Arthritis | Phase 2 | CH | 11 Dec 2014 |
Phase 1/2 | 16 | (99mTc-rhAnnexin V-128: Ankylosing Spondylitis) | (kjgnzlfhgc) = waqegwizgy oipdprseml (fqvjdxzxkv, ioclejytme - wwlywuhpxy) View more | - | 09 Jun 2020 | ||
(99mTc-rhAnnexin V-128: Rheumatoid Arthritis) | (kjgnzlfhgc) = njgrnigelx oipdprseml (fqvjdxzxkv, eyhkynulwi - pqiluhboyh) View more | ||||||
Phase 2 | 5 | agyyplrgwb(hmoglvscic) = lhjycjtlkb efrrroaojj (xxxmeguanu, qkutfzouxk - xphvmiqsqp) View more | - | 13 Dec 2019 |